BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17143524)

  • 1. Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer.
    Lukits J; Remenár E; Rásó E; Ladányi A; Kásler M; Tímár J
    Int J Oncol; 2007 Jan; 30(1):155-60. PubMed ID: 17143524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
    Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
    J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
    Murphy LC; Hilsenbeck SG; Dotzlaw H; Fuqua SA
    Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
    Kunc M; Biernat W; Senkus-Konefka E
    Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors.
    Shupnik MA; Pitt LK; Soh AY; Anderson A; Lopes MB; Laws ER
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3965-72. PubMed ID: 9814476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
    Layfield LJ; Saria EA; Conlon DH; Kerns BJ
    J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S; Mangia A; D'Amico C; Simone G
    Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms.
    Liu J; Chen G; Meng XY; Liu ZH; Dong S
    Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J; Ulm R; Bieglmayer C; Husslein P
    Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
    Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
    Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptor isoforms: clinical significance in breast cancer.
    Fuqua SA; Cui Y
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S3-10. PubMed ID: 15597215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
    Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
    Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
    Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
    Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.